Abstract
Obesity contributes to the development of cardiac disease in several ways. It is both an independent risk factor for cardiovascular disease and a facilitative risk factor for coronary artery disease and its complications through its association with a variety of other traditional and nontraditional risk factors. Central obesity is a key component of the metabolic syndrome. There is substantial epidemiologic evidence of an association between overweightness and obesity and coronary heart disease. Evidence of an association based on autopsy and coronary angiography is less convincing. An increasing body of evidence supports the existence of an obesity paradox with respect to mortality in patients with coronary heart disease once it is established. Whether purposeful weight loss improves cardiovascular outcomes in overweight or obese patients is uncertain. Obesity is also a risk factor for the development of heart failure and may serve as the sole or predominant cause in individuals who are severely obese. Obesity produces alterations in cardiac hemodynamics and cardiac morphology that may predispose to left ventricular diastolic and less commonly systolic dysfunction. Prolonged exposure to these conditions and the presence of comorbidities such as hypertension, sleep apnea, and obesity hyperventilation predispose to heart failure. Purposeful weight loss is capable of reversing most of the abnormalities of cardiac structure and function associated with obesity. To an even greater extent than with coronary artery disease, an obesity paradox exists with respect to heart failure such that the risk of mortality is lower in overweight and mildly obese persons than in underweight or normal weight individuals.
References
Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006; 113:898–918.
Alexander JK. Obesity and coronary heart disease. In:Alpert MA and Alexander JK, eds. The Heart and Lung Obesity. Mt. Armonk NY: Futura Publishing Co; 1998: 213–238.
Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep. 2002; 4: 448–453.
Alexander JK, Obesity and coronary heart disease. Am J Med Sci 2001; 321:215–224.
Barrett-Connor EL: Obesity atherosclerosis and coronary heart disease. Ann Intern Med. 1985; 103:1010–1019.
Jahangir E, DeSchutter A, Lavie CJ. The relation between obesity and coronary artery disease. Translational Res 2014; 164:336–344.
Sjostrum LV: Morbidity of severely obese subjects. Am J Clin Nutr 55:508S-515S, 1992.
Krauss R, Winston M. Obesity Impact on cardiovascular disease. Circulation. 1998; 98: 1472–1476.
Miller MT, Lavie CJ, White CJ. Impact of obesity on the pathogeneses and prognosis of coronary heart diseases. J Cardiometabolic Syndr 2008; 3:162–167.
Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008; 88:389–419.
Wong C, Marwick TH. Obesity cardiomyopathy. Pathogenesis and pathophysiology. Nature Clin Pract Cardiovasc Med. 2007; 4:436–443.
Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014; 56:391–400 (b).
Alpert MA, Agrawal H, Aggarwal K, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations and management. 2014; Translational Res. 2014; 164:345–356 (a).
Alpert MA. Obesity cardiomyopathy. Pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001; 321:225–236.
Massie B. Obesity and heart failure-risk factor or mechanism? N Eng J of Med 2002; 347:358–359.
Alpert MA, Agrawal H, Aggarwal K, Kumar SA, Kumar A. Heart failure and obesity in adults. Pathophysiology, clinical manifestations and management. Curr Heart Failure Rep 2014; 11:156–165 (b).
World Health Organization technical report 894. Obesity: Preventing and managing the global epidemic. Geneva, World Health Organization, 2000.
Bastien N, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014; 56:369–381.
Nicklas B, Berman D, Penninx B et al., Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care. 2014; 26:1413–1420.
Freedman DS, Dietz WH, Srinivasan SR, et al. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999; 103:1175–1181.
Berenson G, Wattigney W, Tracy R, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons age 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). American Journal of Cardiology. 1992; 70:851–858.
Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012; 126:1301–1313.
Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio S, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011; 377:1085–1095.
Lakka HM, Laaksonen D, Lakka T, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-age men. J Am Med Assoc. 2002; 288:2709–2716.
Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24:683–689.
Schulte H, Cullen P, Assmann G. Obesity mortality and cardiovascular disease in the Munster Heart Study (PROCAM). Atherosclerosis. 1999; 144:199–209.
27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. September 14–15, 1995. J Am Coll Cardiol. 1996; 27:957.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67:968–977.
Harris T, Cook F, Garrison R, et al. Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. J Am Med Assoc. 1998; 259:1520–1524.
Kannel W, Cupples L, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease: the Framingham study. J Clin Epidemiol. 1991; 44:183–190.
Kannel W, D Agostino R, Cobb J. Effect of weight on cardiovascular disease. Am J Clin Nutrition 1996; 63:S419–421.
Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002; 162:1867–1872.
Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990; 322:822–889.
Manson J, Willett W, Stampfer M, et al. Body weight and mortality among women. N Eng J Med. 1995; 333:677–685.
Willett W, Manson J, Stampfer M, et al. Weight, weight change and coronary heart disease in women. J Amer Med Assoc.1995; 276:461–465.
Rexrode K, Hennekens C, Willett W, et al. A prospective study of body mass index, weight change, and risk of stroke in women. J Amer Med Assoc. 1997; 277:1539–1545.
Rexrode K, Carey V, Hennekens C, et al. 1998. Abdominal adiposity and coronary heart disease in women. J Amer Med Assoc. 1998; 280: 1843–1848.
Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in U.S. women. Circulation. 2008; 117:1658–1667.
Cho E, Colditz G, Manson J, et al. A prospective study of obesity and risk of coronary heart disease among diabetic women Diabetes Care. 2002; 35:1142–1148.
Baik I, Ascherio A, Rimm E, et al. Adiposity and mortality in men. Amer J Epidemiol. 2000; 152: 264–271.
Rimm E, Stampfer M, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older U.S. men. Amer J Epidemiol. 1995; 141(12):1117–1127.
Field A, Coakley E, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001; 161:1581–1586.
Harris T, Ballard-Barbasch R, Madans J, et al. Overweight, weight loss and risk of coronary heart disease in older women. Amer J Epidemiol. 1993; 137:1318–1327.
Harris T, Launer L, Madans J, et al. Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. British Med J. 1997; 314:1791–1792.
Calle EE, Thun MJ, Petielli JM, et al. Body mass index and mortality in a prospective cohort of U.S. Adults. N Engl J Med. 1999; 341:1097–1105.
Adams-Campbell K, Pensiton RL, Kim KS, Nensa E. Body mass index and coronary artery disease in African-Americans. Obes Res. 1995; 3:215–219.
Zhou B, Wu Y, Li Y, et al. 2002. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obesity Rev. 2002; 3:147–156.
Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight of development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol. 1977; 39:452–458.
Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013; 159:758–769.
Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. J Am Med Assoc Intern Med. 2014; 174:15–22.
Jousilahti P, Tumilehto J, Vartiainen E, et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in Eastern Finland. Circulation. 1996; 93:1372–1379.
Singh P, Landsted K. Body mass and 26-year risk of mortality from specific diseases among women who never smoked. Epidemiology. 1998; 9:246–254.
Spadaro J, Dyer A, Stamler J, et al. Measures of adiposity and coronary heart disease mortality in the Chicago Western Electric Company Study. J Clin Epidemiol. 1996; 49:849–857.
Stevens J, Keil JE, Rust PF, et al. Body mass index and body girth as predictors of mortality in black and white women. Arch Intern Med. 1992; 52:1557–1562.
Shaper A, Wannamethee S, Walker M. Body weight: implications for the prevention of coronary heart disease, stroke and diabetes mellitus in a cohort study of middle aged men. British Med J. 1997; 314:1311–1317.
Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participations from 52 countries: a case–control study. Lancet. 2005; 366:1640–1652.
Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004; 364:937–952.
Rao S, Donahue M, Pi-Sunyer F, et al. Obesity as a risk factor in coronary artery disease. Am Heart J. 2001; 142:1102–1107.
Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012; 97:2482–2488.
Kahn H, Austin H, Williamson D, et al. Simple anthropometric indices associated with ischemic heart disease. J Clini Epidemiol. 1996; 49:1017–1024.
Brown WJ, Dobson AJ, Mishra G. What is healthy weight for middle-aged women? Int J Obes Metab Disord. 1998; 22:520–528.
Montenegro MR, Salsberg LA. Obesity, body weight, body length and atherosclerosis. Lab Invest. 1968; 18:594–603.
Sternby NH. Atherosclerosis and body build. Bull WHO. 1976; 53:601–604.
Giertsen JC. Atherosclerosis in an autopsy series. Acta Pathol Microbiol Scand. 1966; 67:305–321.
Ackerman RF, Dry TJ, Edwards JE. Relationship of various factors to degree of coronary atherosclerosis in women. Circulation. 1950; 1:1345–1350.
Yater WM, Traum AH, Spring S, et al. Coronary artery disease in men 18–39 years of age. Am Heart J. 1948; 36:334–372.
Lee KT, Thomas WA. Relationship of body weight to acute myocardial infarction. Am Heart J. 1956; 52:581–591.
Wilens SL: Bearing of general nutritional state on atherosclerosis. Arch Intern Med. 1947; 79:129–147.
McGill HC Jr., McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002; 105:2712–2718.
McGill HC Jr., McMahan CA, Mulcom GT, Oalmanin MC, Strong JP. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinates of Atherosclerosis in Youth. Atherosclerosis Thomb Vasc Biol. 1995; 15:431–40.
Strong JP, Oalmann MC, Newman WP II, et al. Coronary heart disease in young black and white males in New Orleans Community Pathology Study. Am Heart J. 1984; 108:747–759.
Patel YC, Eggen DA, Strong JP. Obesity, smoking and atherosclerosis: A study of inter-associations. Atherosclerosis. 1983; 36:187–198.
Bjurulf P. Atherosclerosis and body build. Acta Med Scand. 1959; 349 (Suppl): 1–99.
Rhoads G Kagan A. The relation of coronary disease, stroke and morality to weight in youth and in middle age. Lancet. 1983; 16:492–495.
Wilkens RH, Roberts JC Jr. Moser C. Autopsy studies in atherosclerosis. Circulation. 1959; 20: 527–536.
Reed D, Yano K. Predictors of arteriographically defined coronary stenosis in the Honolulu Heart Program. Am J Epidemiol. 1991; 134:111–122.
Cramer K, Paulin S, Werko L. Coronary angiographic findings in correlation with age, body weight, blood pressure, serum lipids, and smoking habits. Circulation. 1966; 33, 888–900.
Stalls CM, Triplette MA, Viera AJ, et al. The association between body mass index and coronary artery disease severity: a comparison of black and white patients. Am Heart J. 2014; 167:514–520.
Hujamuta K, Toshima H, Koga Y et al. Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis. Jpn Circ J. 1990; 45:442–447.
Flynn MA, Cogg MN, Gibney MJ et al.: Indices of obesity and body fat distribution in arteriographically defined coronary artery disease in men. Irish J Med Sci. 1993; 162:503–509.
Rossi R, Iaccarino D, Nuzzo A, et al. Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease. Nutr Metab Cardiovasc Dis. 2011; 21: 86–93.
Morricone L, Ferrari M, Enrini R, et al. Angiographically determined coronary artery disease in relation to obesity and body fat distribution. Int J Obes. 1996; 20(Suppl 4):109–114.
Anderson AJ, Barboriak JJ, Rimm AA: Risk factors and angiographically determined coronary occlusion. Am J Epidemiol. 1978; 107:8–14.
Hauner H, Stangl K, Schmatz C, et al. Body fat distribution in men with angiographically confirmed coronary artery disease. Atherosclerosis. 1990; 85:203–210.
Clark LT, Karve NM, Rones KT, et al. Obesity, distribution of body fat and coronary disease in black women. Am J Cardiol. 1994; 73:895–896.
Kramer JR, Matsuda Y, Mulligan JC, et al. Progression of coronary atherosclerosis. Circulation. 1991; 63:519–526.
Zamboni M, Armellini F, Sheiban I, et al.: Relation of body fat distribution in men and degree of coronary narrowing’s in coronary artery disease. Am J Cardiol. 1992; 70:1135–1138.
Mahoney L, Burns T, Stanford W, et al. Coronary risk factors measure in childhood and young adult life are associated with coronary artery calcification in young adults: The Muscatine Study. J Am Coll Cardiol. 1996; 27:277–284.
See R, Abdullah SM, McGuine DK, et al. The association of differing measures of overweight and obesity with prevalent atherosclerosis. The Dallas Heart Study. J Am Coll Cardiol 2007; 50:752–759.
Labounty TM, Gomez MJ, Achenbach S, et al. Body mass index the prevalence severity and risk of coronary artery disease: an international study of 13,874 patients. Eur Heart J Cardiovasc Imaging. 2013; 14:456–463.
Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009; 53:1925–1932 (a).
Romero-Corral A, Montori VM, Sommers VK, et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006, 368:666–678.
Flegal KM, Kit BK, Orpana H, Graudbard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assoc. 2013; 309:71–82.
Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2011; 58:2642–2650.
Kragelund C, Hassager C, Hildebrandt P, Torp-Pederssen C, Kober L. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol. 2005; 98:121–131.
Pingitore A, Di BG, Lombardi M, et al. The obesity paradox and myocardial infarct size. J Cardiovasc Med. 2007; 8(9):713–717.
Mehta L, Devlin W, McCullough PA et al. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007; 99:906–910.
Gruberg L, Wissman NJ, Wakman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002; 39:578–584.
Li YH, Lin GM, Lin CL, Wang JH, Han CL. Relation of body mass index to mortality among patients with percutaneous coronary intervention longer than 5 years follow-up: a meta-analysis. Int J Cardiol. 2013; 168: 4315–4318.
Lancefield T, Clark DJ, Andrianopoulos N, et al. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. Cardiovasc Interv. 2010; 3:660–668.
Park DW, Kim YH, Yun SC, et al. Association of body mass index with major cardiovascular events and with mortality after percutaneous coronary intervention. Circ Cardiovasc Interv. 2013; 6:146–153.
Sarno G, Raber L, Onuma Y, et al. Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug eluting stents. Am J Cardiol. 2011; 108:195–201.
Nikolsky E, Kosinski E, Mishkel GJ, et al. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). Am J Cardiol. 2005; 95:709–15.
Wang ZJ, Zhou YJ, Zhao YX, et al. Effect of obesity on repeat revascularization in patients undergoing percutaneous coronary intervention with drug-eluting stents. Obesity. 2012; 20:141–146.
Sarno G, Garg S, Onuma Y, et al. The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus-and Sirolimus-eluting stents (from the LEADERS Trial). Am J Cardiol. 2010; 105:475–479.
Akin I, Tolg R, Hochadel M, et al. No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice: results from prospective multicenter German DES DE (German Drug-Eluting Stent) Registry. J Am Coll Cardiol Cardiovasc Interv. 2012; 5:162–169.
Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short-and long-term mortality postcoronary revascularization: a meta-analysis. Obesity. 2008; 16:442–450 (a).
Stamou SC, Nussbaum M, Stiegel RM, et al. Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox. Ann Thorac Surg. 2011; 91:42–47.
Wagner BD, Grunwald GK, Rumsfeld JS, et al. Relationship of body mass index with outcomes after coronary artery bypass graft surgery. Ann Thorac Surg. 2007; 84:10–16.
Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenblood M. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation. 1996; 94(9 Suppl):1187–1192.
Benedetto U, Danese C, Codispoti M. Obesity paradox in coronary artery bypass grafting: myth or reality? J Thorac Cardiovasc Surg. 2014; 147:1517–1523.
Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox and coronary disease. Am J Med. 2009; 122:1106–1114 (b).
Allison DB, Zannolli R, Faith MS, et al. Weight loss increases and fat loss decreases all-cause mortality rate: results from to independent cohort studies. Int J Obes Rel Metab Dis. 1999; 23:603–611.
Owan TE, Hodge DO, Herges, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355:251–9.
Kenchaiah S, Evans J, Levy D, et al. Obesity and the risk of heart failure. N Eng J Med 2002; 347:305–313.
Baena-Diez JM, Bynam AO, Grau M, et al. Obesity as an independent risk factor for heart failure: Zona Franca Cohort Study. Clin Cardiol. 2010; 33:760–764.
Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in morbidly obese patients with and without congestive heart failure. Am J Cardiol. 1997; 80:736–740 (a).
He J, Ogden L, Bazzano L et al. Risk factors for congestive heart failure in US men and women. NHANES I epidemiologic follow-up study. Arch Intern Med. 2001; 161:996–1002.
Alexander JK, Alpert MA, Hemodynamic alterations with obesity in man. In: Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk, NY: Futura Publishing Co; 1998: 45–56 (a).
Alexander JK, Dennis EW, Smith WG, et al. Blood volume, cardiac output and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Center Bull. 1962; 1:39–44.
Alexander JK: Obesity and cardiac performance. Am I Cardiol. 1964;14:860–865.
DeDivitiis O, Fazio S, Petitto M, et al. Obesity and cardiac function. Circulation. 1981; 64:477–482.
Kasper EK, Hruban RH, Baughman KL. Cardiomyopathy of obesity: A clinical pathological evaluation of 43 obese patients with heart failure. Am J Cardiol. 1992; 70:921–924.
Alaud-din A, Meteressian S, Lisbona R, et al. Assessment of cardiac function in patients who were morbidly obese. Surgery. 1982; 92:226–235.
Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med. 1976; 60:645–653.
Backman C, Freyschuss U, Halberg D, et al. Cardiovascular function in extreme obesity. Acta Med. 1973; 193:437–446.
Alpert MA, Alexander JK. Cardiac morphology and obesity in man. In: Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk, NY: Futura Publishing Co; 1998: 25–49 (a).
Smith HL, Willius FA. Adiposity of the heart. Arch Intern Med. 1933; 52:911–931.
Amad RH, Brennan JC, Alexander JK. The cardiac pathology of obesity. Circulation. 1965; 32:740–745.
Alexander JK, Pettigrove JK. Obesity and congestive heart failure. Geriatrics. 1967; 22:101–108.
Warnes CA, Roberts WC. The heart in massive (more than 300 pounds or 136 kilograms) obesity. Analysis of 12 patients studies at necropsy. Am J Cardiol. 1989; 54:1087–1091.
Zema MJ, Caccavano M. Feasibility of detailed M-mode echocardiographic examination in markedly obese adults. Prospective study of 50 patients. J Clin Ultrasound 1982; 10:21–24.
Garcia LC, Laredo C, Arriaga J, et al. Echocardiographic findings in obesity. Rev Invest Clin 1982; 34:235–242.
Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol. 1985; 55:783–786.
Lauer MS, Anderson KM, Kannel WB, et al. The impact of obesity on left ventricular mass and geometry. J Am Med Assoc. 1991; 266:231–236.
Alpert MA, Lambert CR, Terry BE, et al. Effect of weight loss on left ventricular mass in non-hypertensive morbidity obese patients. Am J Cardiol. 1994; 73:918–921.
Bella NJ, Devereutx RB, Roman MJ, et al. Relations of left ventricular mass to fat-free and adipose body mass: The Strong Heart Study. Circulation. 1998; 98:2538–2544
Aurigemma GP, de Simone G, Fitzgibbons TP. Cardiac remodeling in obesity, Circ Cardiovasc Imaging. 2013; 6:442–452.
Turkbey EB, McClelland RL, Kronmal RA, et al. The impact of obesity on the left ventricle; the multi-ethnic study of atherosclerosis (MESA). J Am Coll Cardiol Cardiovasc Imaging 2010; 3:266–274.
Danias RG, Tritos NA, Stuber M, et al. Cardiac structure and function in the obese: a cardiac magnetic resonance imaging study. J Cardiac Res. 2003; 5:431–438.
Messerli FH, Sundgaard-Riise K, Reisin ED, Dreslinski GR, et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med. 1983; 94 757–761.
Woodwiss AJ, Libhaber CD, Majane OHI, et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertension. 2008; 21:1149–1153.
Smalcelj A, Pulievic D, Buljievic B, et al. Left ventricular hypertrophy in obese hypertensives: is it really eccentric? An echocardiographic study. Coll Antropol. 2000; 24:167–183.
Peterson LR, Waggoner AD, Schectman KB, et al. Alterations in left ventricular structure and function in young healthy obese women. J Am Coll Cardiol. 2004; 43:1388–1404.
Okpura IC, Adediran OS, Odia OJ, et al. Left ventricular geometric patterns in obese Nigerian adults: An echocardiographic study. Internet J Intern Med. 2010; 9:1–7.
Iacobellis G, Ribaudo MC, Leto G, et al. Influence of excess fat on cardiac morphology and function and function in uncomplicated obesity. Obes Res. 2002; 10:767–773.
Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Adapted changes in left ventricular structure and function in severe uncomplicated obesity. Obes Res. 2004; 12:1616–1621.
Chakko S, Alpert MA. Obesity and ventricular function in man: Diastolic function. In: Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk, NY: Futura Publishing Co; 1998:57–76.
Stoddard MF, Tseuda K, Thomas M, et al. The influence of obesity on left ventricular filling and systolic function. Am Heart J. 1992; 124:894–899.
Chakko S, Mayor M, Allison MD, et al. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity. Am J Cardiol. 1991; 68:95–98.
Ku CS, Lin S, Wang DJ, et al. Left ventricular filling in young normotensive obese adults. Am J Cardiol. 1994; 73:613–615.
Herszkowicz N, Barbato A, Salvi W, et al. Contribution of Doppler echocardiography to the evaluation of systolic and diastolic function of obese women a control group. Arq Bras Cardiol. 2001; 76:189–196.
Ferraro S, Pessone-Filardo P, Desiderio A, et al. Left ventricular systolic and diastolic function in severe obesity: a radionuclide study. Cardiology. 1996; 82:347–353.
Alpert MA, Lambert CR, Terry BE, et al. Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am J Cardiol. 1997; 80:736–740 (b).
Alpert MA, Lambert CR, Panayiotou H, et al. Relation of duration of morbid obesity to left ventricular mass, systolic function and diastolic filling, and effect of weight loss. Am J Cardiol. 1996; 76:1194–1197.
Nakajima T, Fujioka S, Tokunaga K, et al. Non-invasive study of left ventricular performance in obese patients: Influence of duration of obesity. Circulation. 1985; 71:841–845.
Tian ZQ, Zhong J, Zhao ZG, et al. Relationship between abdominal obesity and left ventricular weight/function. Zhonhua Xin Xue Bing Zen Zhi. 2007; 35:155–158.
Pascual M, Pascual DA, Soria F, et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart. 2003; 89;1152–1156.
Kossaify A, Nicolais N. Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clin Med Insights Cardiol. 2013; 7:43–50.
Talano AC, Bitigen A, Cevik C, et al. The role of tissue Doppler study in the assessment of left ventricular dysfunction in obesity. Acta Cardiol. 2008; 63:541–546.
Alpert MA, Alexander JK. Obesity and ventricular function in man: Systolic function, In: Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk, NY: Futura Publishing Co; 1998: 77–94 (b).
Alpert MA, Terry BE, Lambert CR, et al. Factors infusing left ventricular systolic function in non-hypertensive morbidly obese patients and effect of weight loss induced by gastroplasty. Am J Cardiol. 1993; 75:773–777.
Tumuklu MM, Etikan I, Kucasik B, et al. Effect of obesity on left ventricular structure and myocardial systolic function: assessment by tissue Doppler imaging and strain/strain rate imaging. Echocardiology. 2007; 24:802–809.
Barbosa MM, Beleigoli AM, de Fatima Diniz M, et al. Strain imaging and morbid obesity: insight into subclinical ventricular dysfunction. Clin Cardiol. 2011; 34:288–293.
Otto ME, Belohlavek M, Khandheria B. Comparison of right and left ventricular function in obese and non-obese men. Am J Cardiol. 2004; 93:1569–1572.
Chahai H, McCelland RL, Tandai H, et al. Obesity and right ventricular structure and function: the MESA-Right Ventricular Study. Chest. 2012; 141:388–395.
Orhan AL, Uslu N, Davi SU, et al. Effects of isolated obesity on left and right ventricular function: a tissue Doppler and strain rate imaging study. Echocardiography. 2010; 22:236–243.
Thakur V, Richards R, Reisen E. Obesity, hypertension and the heart. Am J Med Sci. 2001; 321:242–248.
Fazio S, Ferraro S, De Simone G, et al. Hemodynamic adaptation in severe obesity with or without arterial hypertension. Cardiologia. 1989; 34:967–972.
Lavie CJ, Milani RV, Patel D, et al. Disparate effects of hypertension and obesity on left ventricular geometry and mortality in 8088 elderly patients with preserved systolic function. Postgrad Med. 2009; 121:119–125 (c).
Iacobellis G, DiGuardo MC, Zapaterrenno A, et al. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res. 2003; 11:578–584.
Amador N, de Jesus Encarnacion J, Rodriguez L, et al. Relationship between left ventricular mass and heart sympathetic activity in male obese subjects. Arch Med Res. 2004; 34:411–415.
McGavock JM, Victor R, Unger RH, Szczepaniak LS. Adiposity of the heart revisited. Ann Intern Med. 2006; 144:515–524.
Alexander JK, Alpert MA. Pathogenesis and clinical manifestations of obesity cardiomyopathy. In: Alpert MA, Alexander JK, eds. The Heart and Lung in Obesity. Armonk NY: Futura Publishing Co: 1998; 133–146 (b).
Lillington GA, Anderson MW, Brandenburg RO. The cardiorespiratory syndrome of obesity. Dis Chest. 1957; 32:1–20.
Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. J Am Coll Cardiol Heart Failure. 2013; 1:93–102 (a).
Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McCallister FA. Body mass index in heart failure: a meta-analysis. Am Heart J 2008; 156:13–22 (b).
Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001; 38:789.
Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003; 9:29–35.
Clark AL, Chya J, Horwich TB. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol. 2012; 110:77–82.
Padwal R, McCallister FA, McMurry JJ, et al. The obesity paradox in patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obesity. 2014; 38:1110–1114.
Nicklas BJ, Lesari M, Penninx BW, et al. Abdominal obesity is an independent risk factor for heart failure in older people. J Am Geriatric Soc. 2006; 54:413–420.
Fonarow GC, Srikanthan P, Costanzo R, et al. The obesity paradox in acute heart failure: analysis of body mass index and in-hospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007; 15–3:74–81.
Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index and survival in systolic heart failure: the obesity paradox. J Cardiac Fail. 2011; 17:374–380.
Lavie CJ, Cahalin LP, Chase P, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013; 88:251–258 (b).
Ashrafian H, le Roux CW, Darzi A, et al. Effects of bariatric surgery on cardiovascular function. Circulation. 2008; 118:2091–2102.
Rider OJ, Franco JM, Ali MK, et al. Beneficial cardiovascular effects on bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009; 54:718–726.
Alexander JK, Petersen KL. Cardiovascular effects of weight reduction. Circulation. 1992; 45:310–318.
Backman L, Freyschuss U, Hallberg D, et al. Reversibility of cardiopulmonary changes in extreme obesity. Act Med Scand. 1979; 205:367–373.
Grapsa J, Tan TL, Paschou SA, et al. The effect of bariatric surgery on echocardiographic indices: a review of the literature. Eur J Clin Invest. 2013; 42:1224–1230.
Jhaveri RR, Pond KK, Hauser TH, et al. Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery. Surg Obes Relat Dis. 2009; 5:648–652.
Reisin E, Frohlich ED, Messerli FH, et al. Cardiovascular changes after weight loss in obesity hypertension. Ann Intern Med. 1983; 98:315–319.
Luaces M, Cachofeiro V, Garcia-Munoz-Najar A, et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol. 2012; 65:14–21.
De las Fuentes L, Waggoner AD, Mohammad BS, et al. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol. 2009; 54:2376–2381.
Haufe S, Utz W, Engeli S, et al. Left ventricular mass and function with reduced-fat or reduced-carbohydrate hypocaloric diets in overweight and obese subjects. Hypertension. 2012; 59:70–75.
McCloskey CD, Ramani GV, Mathier MA, et al. Bariatric surgery improves cardiac function in morbidly obese patients with serve cardiomyopathy. Surg Obes Relat Dis. 2007; 3:503–507.
Estes EH, Sieker HO, McIntosh HD, et al. Reversible cardiopulmonary syndrome with extreme obesity. Circulation. 1957; 41:179–187.
Miranda WR, Batsis JA, Sarr MG, et al. Impact of bariatric surgery on quality of life, function capacity and symptoms in patients with heart failure. Obes Surg. 2013; 23:1101–1105.
Ramani GY, McClaskey C, Ramanathan RC, Mathies MA, Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008; 31:516–520.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this entry
Cite this entry
Alpert, M.A., Parker, B.M. (2015). Obesity and Cardiac Disease. In: Ahima, R. (eds) Metabolic Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-12125-3_35-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-12125-3_35-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-12125-3
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Obesity and Cardiovascular Disease- Published:
- 25 July 2023
DOI: https://doi.org/10.1007/978-3-319-12125-3_35-2
-
Original
Obesity and Cardiac Disease- Published:
- 16 July 2015
DOI: https://doi.org/10.1007/978-3-319-12125-3_35-1